Description: Shandong Buchang Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of medicines in China. It offers medicines to treat cardiac and cerebral vascular, urinary and digestive, respiratory, gynecological, and other diseases, as well as diabetes. The company was founded in 1993 and is based in Heze, China. Shandong Buchang Pharmaceuticals Co., Ltd. was a former subsidiary of Shanghai Zhangjiang (Group) Co., Ltd.
Home Page: www.buchang.com
No. 369 Zhonghua West Road
Heze,
274000
China
Phone:
86 53 0529 9167
Officers
| Name | Title |
|---|---|
| Mr. Chao Zhao | Pres & Director |
| Mr. Yi Min Wang | Exec. VP & Vice Chairman |
| Mr. Bao Cai Wang | Chief Financial Officer |
| Mr. Ren Hui Xue | VP of Marketing & Director |
| Mr. Xifang Wang | Chief Engineer |
| Mr. Xiao Ping Pu | VP of Securities, Board Sec. & Director |
| Dr. Zhao Buchang M.D. | Founder |
| Haiqin Wu | Chairman of the Academic Committee |
| Ms. Wei Zhao | VP of Procument |
Exchange: SHG
Country: CN : China
Currency: Renminbi (¥)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 18.2672 |
| Price-to-Book MRQ: | 1.888 |
| Price-to-Sales TTM: | 1.775 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 8353 |